We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tissue Created with Biocompatible Embedded Nanoscale Wires

By LabMedica International staff writers
Posted on 10 Sep 2012
For the first time, scientists have created a type of “cyborg” tissue by embedding a three-dimensional (3D) network of functional, biocompatible nanoscale wires into engineered human tissues.

As described in an article published August 26, 2012, in the journal Nature Materials, a multi-institutional research team led by Charles M. More...
Lieber, a professor of chemistry at Harvard University (Cambridge, MA, USA) and Daniel Kohane, a Harvard Medical School professor in the department of anesthesia at Children’s Hospital Boston (MA, USA) developed a system for creating nanoscale “scaffolds,” which could be seeded with cells which later grew into tissue.

“The current methods we have for monitoring or interacting with living systems are limited,” said Prof. Lieber. “We can use electrodes to measure activity in cells or tissue, but that damages them. With this technology, for the first time, we can work at the same scale as the unit of biological system without interrupting it. Ultimately, this is about merging tissue with electronics in a way that it becomes difficult to determine where the tissue ends and the electronics begin.”

The research tackles a problem that has long been associated with research on bioengineered tissue--how to create systems capable of sensing chemical or electrical alterations in the tissue after it has been grown and implanted. The system might also represent a solution to researchers’ struggles in developing methods to directly stimulate engineered tissues and measure cellular reactions.

“In the body, the autonomic nervous system keeps track of pH, chemistry, oxygen, and other factors, and triggers responses as needed,” Prof. Kohane explained. “We need to be able to mimic the kind of intrinsic feedback loops the body has evolved in order to maintain fine control at the cellular and tissue level.”

Using the autonomic nervous system as inspiration, Dr. Bozhi Tian, a former doctoral student under Prof. Lieber and former postdoctoral fellow in the Kohane and Langer labs, and collaborator Dr. Jia Liu worked in Prof. Lieber’s lab at Harvard to construct mesh-like networks of nanoscale silicon wires--approximately 30-80 nm in diameter--shaped like flat planes or in a reticular conformation. The process of building the networks, according to Prof. Lieber, is similar to that used to etch microchips.

Beginning with a two-dimensional (2D) substrate, researchers laid out a mesh of organic polymer around nanoscale wires, which serve as the critical nanoscale sensing elements. Nanoscale electrodes, which connect the nanowire elements, were then built within the mesh to enable nanowire transistors to measure the activity in cells without damaging them. Once complete, the substrate was dissolved, leaving researchers with a net-like sponge or a mesh that can be folded or rolled into a host of 3D shapes.

When finished, the networks were porous enough to allow the scientists to seed them with cells and induce those cells to grow in 3D cultures. “Previous efforts to create bioengineered sensing networks have focused on two-dimensional layouts, where culture cells grow on top of electronic components or on conformal layouts where probes are placed on tissue surfaces,” said Dr. Tian. “It is desirable to have an accurate picture of cellular behavior within the 3D structure of a tissue, and it is also important to have nanoscale probes to avoid disruption of either cellular or tissue architecture."

Using heart and nerve cells, the team successfully engineered tissues containing embedded nanoscale networks without affecting the cells’ viability or activity. Using the embedded devices, they were able to detect electrical signals generated by cells deep within the tissue, and to measure changes in those signals in response to cardio- or neuro-stimulating drugs.

Researchers were also able to construct bioengineered blood vessels, and used the embedded technology to measure pH changes--as would be seen in response to ischemia, inflammation, and other biochemical or cellular environments--both inside and outside the vessels.

Although a number of potential applications exist for the technology, the most near-term use, according to Dr. Lieber, may come from the pharmaceutical industry, where researchers could employ the technology to more precisely examine how newly-developed drugs act in three dimensional tissues, instead of thin layers of cultured cells. The system might also one day be used to track changes inside the body and react accordingly, whether through electrical stimulation or the release of a drug.

Related Links:
Harvard University
Children’s Hospital Boston


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.